OKUR
Price
$4.48
Change
+$0.19 (+4.43%)
Updated
Jun 18 closing price
Capitalization
184.05M
59 days until earnings call
Intraday BUY SELL Signals
RXRX
Price
$3.23
Change
+$0.12 (+3.86%)
Updated
Jun 18 closing price
Capitalization
1.71B
52 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

OKUR vs RXRX

OKUR vs RXRX Comparison Chart in %
View a ticker or compare two or three
VS
OKUR vs. RXRX commentary
Jun 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OKUR is a Hold and RXRX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 20, 2026
Stock price -- (OKUR: $4.48 vs. RXRX: $3.23)
Brand notoriety: OKUR and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: OKUR: 661% vs. RXRX: 146%
Market capitalization -- OKUR: $184.05M vs. RXRX: $1.71B
OKUR [@Biotechnology] is valued at $184.05M. RXRX’s [@Biotechnology] market capitalization is $1.71B. The market cap for tickers in the [@Biotechnology] industry ranges from $114.63B to $0. The average market capitalization across the [@Biotechnology] industry is $1.95B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

OKUR’s FA Score shows that 0 FA rating(s) are green whileRXRX’s FA Score has 1 green FA rating(s).

  • OKUR’s FA Score: 0 green, 5 red.
  • RXRX’s FA Score: 1 green, 4 red.
According to our system of comparison, RXRX is a better buy in the long-term than OKUR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

OKUR’s TA Score shows that 6 TA indicator(s) are bullish while RXRX’s TA Score has 2 bullish TA indicator(s).

  • OKUR’s TA Score: 6 bullish, 4 bearish.
  • RXRX’s TA Score: 2 bullish, 8 bearish.
According to our system of comparison, OKUR is a better buy in the short-term than RXRX.

Price Growth

OKUR (@Biotechnology) experienced а +5.41% price change this week, while RXRX (@Biotechnology) price change was +2.54% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.61%. For the same industry, the average monthly price growth was +8.78%, and the average quarterly price growth was +2225.89%.

Reported Earning Dates

OKUR is expected to report earnings on Aug 18, 2026.

RXRX is expected to report earnings on Aug 11, 2026.

Industries' Descriptions

@Biotechnology (+2.61% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.71B) has a higher market cap than OKUR($184M). OKUR YTD gains are higher at: 54.483 vs. RXRX (-21.027). OKUR has higher annual earnings (EBITDA): -57.3M vs. RXRX (-478.66M). RXRX has more cash in the bank: 654M vs. OKUR (192M). OKUR has less debt than RXRX: OKUR (409K) vs RXRX (72.4M). RXRX has higher revenues than OKUR: RXRX (65.7M) vs OKUR (0).
OKURRXRXOKUR / RXRX
Capitalization184M1.71B11%
EBITDA-57.3M-478.66M12%
Gain YTD54.483-21.027-259%
P/E Ratio62.48N/A-
Revenue065.7M-
Total Cash192M654M29%
Total Debt409K72.4M1%
TECHNICAL ANALYSIS
Technical Analysis
OKURRXRX
RSI
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
79%
Bullish Trend 3 days ago
81%
Momentum
ODDS (%)
Bullish Trend 3 days ago
79%
Bearish Trend 3 days ago
89%
MACD
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
85%
Bullish Trend 3 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
89%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 9 days ago
83%
Declines
ODDS (%)
Bearish Trend 11 days ago
90%
Bearish Trend 4 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
OKUR
Daily Signal:
Gain/Loss:
RXRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPYU33.571.25
+3.87%
MAX S&P 500 4X Leveraged ETN
FYC120.422.53
+2.15%
First Trust Small Cap Gr AlphaDEX® ETF
SNAV38.380.33
+0.87%
Mohr Sector Nav ETF
PRFD51.200.01
+0.02%
PIMCO Preferred and Cp Sec Act Exc-Trd
MMMA25.44N/A
N/A
NYLI MacKay Muni Allocation ETF

OKUR and

Correlation & Price change

A.I.dvisor indicates that over the last year, OKUR has been loosely correlated with MGX. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if OKUR jumps, then MGX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OKUR
1D Price
Change %
OKUR100%
+4.43%
MGX - OKUR
37%
Loosely correlated
+1.69%
NRIX - OKUR
35%
Loosely correlated
+2.51%
RXRX - OKUR
32%
Poorly correlated
+3.86%
IDYA - OKUR
31%
Poorly correlated
-0.10%
CABA - OKUR
31%
Poorly correlated
N/A
More